|
DONSON expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62891922173003E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.54791801177635E-15 |
| Normal-vs-Stage2 |
6.183700E-02 |
| Normal-vs-Stage3 |
3.1770031050371E-11 |
| Normal-vs-Stage4 |
1.5174994594247E-10 |
| Stage1-vs-Stage2 |
4.015700E-04 |
| Stage1-vs-Stage3 |
9.486000E-01 |
| Stage1-vs-Stage4 |
3.803700E-02 |
| Stage2-vs-Stage3 |
1.542480E-03 |
| Stage2-vs-Stage4 |
6.27659999999919E-05 |
| Stage3-vs-Stage4 |
7.371700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62569957495862E-12 |
| Normal-vs-AfricanAmerican |
1.62653999999929E-05 |
| Normal-vs-Asian |
5.61960034062281E-10 |
| Caucasian-vs-AfricanAmerican |
9.814400E-02 |
| Caucasian-vs-Asian |
4.001600E-01 |
| AfricanAmerican-vs-Asian |
3.660600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39763764398049E-12 |
| Normal-vs-Female |
3.08642000845794E-14 |
| Male-vs-Female |
5.668200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
3.99920097038375E-11 |
| Normal-vs-Age(61-80Yrs) |
5.16679999895686E-08 |
| Normal-vs-Age(81-100Yrs) |
1.228930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.198300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.642200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.919400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.968800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.713000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.518000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.019200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
5.329200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.07800002258074E-09 |
| Tall-VS-Other |
2.832400E-01 |
| Tall-VS-Normal |
3.27882165862547E-12 |
| Follicular-VS-Other |
1.473740E-02 |
| Follicular-VS-Normal |
5.509000E-01 |
| Other-VS-Normal |
4.817300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98189999967013E-08 |
| Normal-vs-N1 |
4.20400381173636E-11 |
| N0-vs-N1 |
2.322900E-03 |
|
|
